Minimal Residual Disease Studies by Flow Cytometry in Acute Leukemia

Publisher： Karger

E-ISSN： 1421-9662|112|1-2|8-15

ISSN： 0001-5792

Source： Acta Haematologica, Vol.112, Iss.1-2, 2004-06, pp. : 8-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Detection of Minimal Residual Disease in Acute Myelogenous Leukemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

Immunological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 442-448

Karger

Access to resources Recommend Favorite

Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Current Status and Challenges

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 34-39

Karger

Access to resources Recommend Favorite

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1514-1519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal residual disease as biomarker for optimal biologic dosing of ARA‐C in patients with acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 125-131

John Wiley & Sons Inc

Access to resources Recommend Favorite